174 related articles for article (PubMed ID: 19626035)
1. PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas.
Sand JM; Aziz MH; Dreckschmidt NE; Havighurst TC; Kim K; Oberley TD; Verma AK
J Invest Dermatol; 2010 Jan; 130(1):270-7. PubMed ID: 19626035
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3.
Aziz MH; Manoharan HT; Verma AK
Cancer Res; 2007 Feb; 67(3):1385-94. PubMed ID: 17283176
[TBL] [Abstract][Full Text] [Related]
3. Ultraviolet radiation and 12-O-tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase Cε with Stat3 involve integration with ERK1/2.
Sand JM; Bin Hafeez B; Aziz MH; Siebers EM; Dreckschmidt NE; Verma AK
Mol Carcinog; 2012 Apr; 51(4):291-302. PubMed ID: 21480396
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas.
Wheeler DL; Martin KE; Ness KJ; Li Y; Dreckschmidt NE; Wartman M; Ananthaswamy HN; Mitchell DL; Verma AK
Cancer Res; 2004 Nov; 64(21):7756-65. PubMed ID: 15520180
[TBL] [Abstract][Full Text] [Related]
5. Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals.
Singh A; Singh A; Bauer SJ; Wheeler DL; Havighurst TC; Kim K; Verma AK
Carcinogenesis; 2016 Jan; 37(1):72-80. PubMed ID: 26586792
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C epsilon signals ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through Induction of specific cytokines in a paracrine mechanism.
Wheeler DL; Li Y; Verma AK
Photochem Photobiol; 2005; 81(1):9-18. PubMed ID: 15458367
[TBL] [Abstract][Full Text] [Related]
7. Topically applied Hsp90 inhibitor 17AAG inhibits UVR-induced cutaneous squamous cell carcinomas.
Singh A; Singh A; Sand JM; Bauer SJ; Hafeez BB; Meske L; Verma AK
J Invest Dermatol; 2015 Apr; 135(4):1098-1107. PubMed ID: 25337691
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase Cepsilon interacts with Stat3 and regulates its activation that is essential for the development of skin cancer.
Aziz MH; Manoharan HT; Sand JM; Verma AK
Mol Carcinog; 2007 Aug; 46(8):646-53. PubMed ID: 17583567
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma.
Jansen AP; Verwiebe EG; Dreckschmidt NE; Wheeler DL; Oberley TD; Verma AK
Cancer Res; 2001 Feb; 61(3):808-12. PubMed ID: 11221859
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cepsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer.
Verma AK; Wheeler DL; Aziz MH; Manoharan H
Mol Carcinog; 2006 Jun; 45(6):381-8. PubMed ID: 16683253
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C delta overexpressing transgenic mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas: a possible link to specific cytokines and cyclooxygenase-2.
Aziz MH; Wheeler DL; Bhamb B; Verma AK
Cancer Res; 2006 Jan; 66(2):713-22. PubMed ID: 16424000
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
Wheeler DL; Ness KJ; Oberley TD; Verma AK
Cancer Res; 2003 Oct; 63(19):6547-55. PubMed ID: 14559850
[TBL] [Abstract][Full Text] [Related]
13. Sun-sensitizing effects of PKCepsilon shine on multiple mouse strains.
Denning MF
J Invest Dermatol; 2010 Jan; 130(1):17-9. PubMed ID: 20010864
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas.
Sand JM; Bin Hafeez B; Jamal MS; Witkowsky O; Siebers EM; Fischer J; Verma AK
Carcinogenesis; 2012 Jan; 33(1):184-90. PubMed ID: 22072620
[TBL] [Abstract][Full Text] [Related]
15. Early epidermal destruction with subsequent epidermal hyperplasia is a unique feature of the papilloma-independent squamous cell carcinoma phenotype in PKCepsilon overexpressing transgenic mice.
Li Y; Wheeler DL; Alters W; Chaiswing L; Verma AK; Oberley TD
Toxicol Pathol; 2005; 33(6):684-94. PubMed ID: 16243773
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet radiation-induced differential microRNA expression in the skin of hairless SKH1 mice, a widely used mouse model for dermatology research.
Singh A; Willems E; Singh A; Ong IM; Verma AK
Oncotarget; 2016 Dec; 7(51):84924-84937. PubMed ID: 27793049
[TBL] [Abstract][Full Text] [Related]
17. Repeated treatments with ingenol mebutate for prophylaxis of UV-induced squamous cell carcinoma in hairless mice.
Erlendsson AM; Thaysen-Petersen D; Bay C; Lerche CM; Philipsen PA; Wulf HC; Zibert JR; Hædersdal M
J Photochem Photobiol B; 2016 Oct; 163():144-9. PubMed ID: 27567085
[TBL] [Abstract][Full Text] [Related]
18. Impact of UVR Exposure Pattern on Squamous Cell Carcinoma-A Dose-Delivery and Dose-Response Study in Pigmented Hairless Mice.
Lerche CM; Togsverd-Bo K; Philipsen PA; Wulf HC
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258202
[TBL] [Abstract][Full Text] [Related]
19. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet radiation-induced tumor necrosis factor alpha, which is linked to the development of cutaneous SCC, modulates differential epidermal microRNAs expression.
Singh A; Willems E; Singh A; Hafeez BB; Ong IM; Mehta SL; Verma AK
Oncotarget; 2016 Apr; 7(14):17945-56. PubMed ID: 26918454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
